rs6791

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006949.4(STXBP2):​c.1576A>G​(p.Ile526Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.63 in 1,613,250 control chromosomes in the GnomAD database, including 324,031 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 35051 hom., cov: 33)
Exomes 𝑓: 0.63 ( 288980 hom. )

Consequence

STXBP2
NM_006949.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: -0.234
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.451353E-7).
BP6
Variant 19-7647391-A-G is Benign according to our data. Variant chr19-7647391-A-G is described in ClinVar as [Benign]. Clinvar id is 260094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-7647391-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.803 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
STXBP2NM_006949.4 linkuse as main transcriptc.1576A>G p.Ile526Val missense_variant 18/19 ENST00000221283.10 NP_008880.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkuse as main transcriptc.1576A>G p.Ile526Val missense_variant 18/191 NM_006949.4 ENSP00000221283 P4Q15833-1

Frequencies

GnomAD3 genomes
AF:
0.673
AC:
102229
AN:
151992
Hom.:
35002
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.772
Gnomad AMI
AF:
0.689
Gnomad AMR
AF:
0.675
Gnomad ASJ
AF:
0.505
Gnomad EAS
AF:
0.824
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.612
Gnomad OTH
AF:
0.648
GnomAD3 exomes
AF:
0.634
AC:
156856
AN:
247224
Hom.:
50816
AF XY:
0.623
AC XY:
83842
AN XY:
134664
show subpopulations
Gnomad AFR exome
AF:
0.776
Gnomad AMR exome
AF:
0.647
Gnomad ASJ exome
AF:
0.510
Gnomad EAS exome
AF:
0.815
Gnomad SAS exome
AF:
0.494
Gnomad FIN exome
AF:
0.728
Gnomad NFE exome
AF:
0.613
Gnomad OTH exome
AF:
0.635
GnomAD4 exome
AF:
0.625
AC:
913822
AN:
1461140
Hom.:
288980
Cov.:
88
AF XY:
0.621
AC XY:
451111
AN XY:
726860
show subpopulations
Gnomad4 AFR exome
AF:
0.783
Gnomad4 AMR exome
AF:
0.655
Gnomad4 ASJ exome
AF:
0.509
Gnomad4 EAS exome
AF:
0.849
Gnomad4 SAS exome
AF:
0.492
Gnomad4 FIN exome
AF:
0.721
Gnomad4 NFE exome
AF:
0.620
Gnomad4 OTH exome
AF:
0.634
GnomAD4 genome
AF:
0.673
AC:
102340
AN:
152110
Hom.:
35051
Cov.:
33
AF XY:
0.676
AC XY:
50271
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.772
Gnomad4 AMR
AF:
0.674
Gnomad4 ASJ
AF:
0.505
Gnomad4 EAS
AF:
0.823
Gnomad4 SAS
AF:
0.507
Gnomad4 FIN
AF:
0.735
Gnomad4 NFE
AF:
0.612
Gnomad4 OTH
AF:
0.651
Alfa
AF:
0.621
Hom.:
37556
Bravo
AF:
0.678
TwinsUK
AF:
0.632
AC:
2345
ALSPAC
AF:
0.616
AC:
2375
ESP6500AA
AF:
0.775
AC:
3404
ESP6500EA
AF:
0.612
AC:
5251
ExAC
AF:
0.632
AC:
76700
Asia WGS
AF:
0.676
AC:
2352
AN:
3478
EpiCase
AF:
0.609
EpiControl
AF:
0.602

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 86% of patients studied by a panel of primary immunodeficiencies. Number of patients: 83. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Familial hemophagocytic lymphohistiocytosis 5 Benign:4
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtDec 09, 2015- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
not provided Benign:1Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Familial hemophagocytic lymphohistiocytosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.028
DANN
Benign
0.25
DEOGEN2
Benign
0.058
.;T;.;T
Eigen
Benign
-2.0
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.060
T;T;T;T
MetaRNN
Benign
9.5e-7
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.75
.;N;.;.
MutationTaster
Benign
1.0
P;P;P
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.59
N;N;N;.
REVEL
Benign
0.11
Sift
Benign
0.54
T;T;T;.
Sift4G
Benign
0.63
T;T;T;T
Polyphen
0.0
.;B;B;.
Vest4
0.010
MPC
0.20
ClinPred
0.0018
T
GERP RS
-0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.025
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6791; hg19: chr19-7712277; COSMIC: COSV55401668; COSMIC: COSV55401668; API